Pyxis Oncology to Participate in Fireside Chat at BofA Securities 2022 Healthcare Conference
27 April 2022 - 8:35PM
Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset multi-modality
company focused on developing next-generation therapeutics for
difficult to treat cancers, today announced that Lara Sullivan,
M.D., President and Chief Executive Officer, will participate in a
fireside chat at the BofA Securities 2022 Healthcare Conference on
Wednesday, May 11, 2022 at 2:40 p.m. PT in Las Vegas, Nevada.
A webcast of the fireside chat can be accessed on the Investors
section of the Pyxis Oncology website at ir.pyxisoncology.com.
Following the live event, a replay of the webcast will be archived
for up to 90 days.
About Pyxis Oncology, Inc. Pyxis Oncology, Inc.
is a multi-asset multi-modality company focused on defeating
difficult to treat cancers and improve patient lives. By leveraging
our fully integrated research, development and commercial
capabilities, our expert team is efficiently building a diversified
portfolio of next-generation therapeutics. Pyxis Oncology’s
therapeutic candidates are designed to directly kill tumor cells,
and to address the underlying pathologies created by cancer that
enable its uncontrollable proliferation and immune evasion. Since
its launch in 2019, Pyxis Oncology has developed a broad portfolio
of novel antibody drug conjugate, or ADC, product candidates, and
monoclonal antibody, or mAb, preclinical discovery programs that it
is developing as monotherapies and in combination with other
therapies. To learn more about Pyxis Oncology visit
www.pyxisoncology.com.
Pyxis Oncology Contact:Courtney DuganVice
President, Head of Investor Relations & Corporate
Communications(617) 500-8872
Pyxis Oncology (NASDAQ:PYXS)
Historical Stock Chart
From Apr 2024 to May 2024
Pyxis Oncology (NASDAQ:PYXS)
Historical Stock Chart
From May 2023 to May 2024